Skip to main content
TipRanks
Go Ultimate75% OFF

Pharming Group (PHG) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Pharming Group has a market cap or net worth of EUR 807.58M. The enterprise value is EUR 670.87M.

Market Cap
EUR 807.58M
Enterprise Value
EUR 670.87M

Share Statistics

Pharming Group has 70,778,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
70,778,120
Owned by Insiders
―
Owned by Institutions
0.09%

Financial Efficiency

Pharming Group’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 1.05%.

Return on Equity (ROE)
0.01
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
1.05%
Return on Capital Employed (ROCE)
0.05
Revenue Per Employee
924.16K
Profits Per Employee
7,004.914
Employee Count
407
Asset Turnover
0.75
Inventory Turnover
0.70

Valuation Ratios

The current PE Ratio of Pharming Group is 35.72. Pharming Group’s PEG ratio is 0.00.

PE Ratio
35.72
PS Ratio
2.30
PB Ratio
3.11
Price to FCF
28.97
Price to Operating Cash Flow
28.17
PEG Ratio
0.00

Income Statement

In the last 12 months, Pharming Group had revenue of 376.13M and earned 2.85M in profits. Earnings per share was 0.04.

Revenue
376.13M
Gross Profit
330.63M
Operating Income
20.88M
Pretax Income
12.85M
Net Income
2.85M
EBITDA
34.78M
Earnings Per Share (EPS)
0.04

Cash Flow

In the last 12 months, operating cash flow was 32.52M and capital expenditures -869,396, giving a free cash flow of 31.65M billion.

Operating Cash Flow
32.52M
Free Cash Flow
31.65M
Free Cash Flow per Share
0.43

Dividends & Yields

Pharming Group pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
3.45%
Earnings Yield
2.74%

Stock Price Statistics

Beta
0.71
52-Week Price Change
2.75%
50-Day Moving Average
9.31
200-Day Moving Average
11.17
Relative Strength Index (RSI)
67.95
Average Volume (3m)
275

Important Dates

Pharming Group upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 27, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Pharming Group as a current ratio of 2.59, with Debt / Equity ratio of 41.79%

Current Ratio
2.59
Quick Ratio
2.03
Debt to Market Cap
0.08
Net Debt to EBITDA
-0.87
Interest Coverage Ratio
1.95

Taxes

In the past 12 months, Pharming Group has paid 10.31M in taxes.

Income Tax
10.31M
Effective Tax Rate
0.80

Enterprise Valuation

Pharming Group EV to EBITDA ratio is 19.03, with an EV/FCF ratio of 26.60.

EV to Sales
2.11
EV to EBITDA
19.03
EV to Free Cash Flow
26.60
EV to Operating Cash Flow
25.87

Balance Sheet

Pharming Group has EUR 189.56M in cash and marketable securities with EUR 114.51M in debt, giving a net cash position of EUR 75.05M billion.

Cash & Marketable Securities
EUR 189.56M
Total Debt
EUR 114.51M
Net Cash
EUR 75.05M
Net Cash Per Share
EUR 1.06
Tangible Book Value Per Share
EUR 2.34

Margins

Gross margin is 84.34%, with operating margin of 6.89%, and net profit margin of 6.30%.

Gross Margin
84.34%
Operating Margin
6.89%
Pretax Margin
8.93%
Net Profit Margin
6.30%
EBITDA Margin
11.09%
EBIT Margin
7.96%

Analyst Forecast

The average price target for Pharming Group is EUR 34.92, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 34.92
Price Target Upside
211.77% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
1.73%
EPS Growth Forecast
―

Scores

Smart Score
7
AI Score
―